BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32427884)

  • 21. Long Noncoding RNA
    Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
    Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
    An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
    Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamine stimulates biosynthesis and secretion of insulin-like growth factor 2 (IGF2), an autocrine regulator of beta cell mass and function.
    Modi H; Cornu M; Thorens B
    J Biol Chem; 2014 Nov; 289(46):31972-31982. PubMed ID: 25271169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.
    Hua X; Huang M; Deng X; Xu J; Luo Y; Xie Q; Xu J; Tian Z; Li J; Zhu J; Huang C; Zhao QS; Huang H; Huang C
    Cell Death Differ; 2020 Feb; 27(2):632-645. PubMed ID: 31243344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
    Schaefer T; Steiner R; Lengerke C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
    J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.
    Catalano R; Giardino E; Treppiedi D; Mangili F; Morelli V; Elli FM; Serban AL; Luconi M; Mannelli M; Spada A; Arosio M; Mantovani G; Peverelli E
    Cancer Lett; 2021 Jan; 497():77-88. PubMed ID: 33075426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation.
    Vella V; Nicolosi ML; Giuliano M; Morrione A; Malaguarnera R; Belfiore A
    Cells; 2019 Sep; 8(9):. PubMed ID: 31480557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
    Li Y; Zhang X; Zhou X; Zhang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
    Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
    J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis.
    Dallinga MG; Habani YI; Kayser RP; Van Noorden CJF; Klaassen I; Schlingemann RO
    Mol Biol Rep; 2020 Apr; 47(4):2561-2572. PubMed ID: 32133604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
    BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
    Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
    Zhang X; Shao J; Li X; Cui L; Tan Z
    Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.